2 withdrawn. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Foot Diseases: new trials by email Literature Review of Foot Diseases trials Research Report on Foot Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Safety, Tolerability, and Pharmacokinetics of Topical Selinexor (KPT-330) Diabetic Foot Ulcer (DFU) Patients Selinexor, Standard-of-Care, Vehicle Gel - Diabetic Foot Ulcers | Phase 1 / Phase 2 | Withdrawn | Karyopharm Therapeutics Inc | 2015-01-01 | 2023-01-20 | |
| Comparing Steroid Injections and Platelet Rich Plasma Injections in the Treatment of Plantar Fasciitis Corticosteroid injection (Bupivacaine and Depo Medrol), Platelet rich plasma injection - Plantar Fasciitis | Phase 2 / Phase 3 | Withdrawn | King Hamad University Hospital, Bahrain | 2013-06-01 | 2019-08-16 |
Diabetes Mellitus (1) · Diabetic Foot (1) · Fasciitis, Plantar (1) · Foot Ulcer (1)
Cardiovascular Diseases (1) · Diabetes Complications (1) · Diabetic Angiopathies (1) · Diabetic Neuropathies (1) · Endocrine System Diseases (1) · Fasciitis (1) · Glucose Metabolism Disorders (1) · Leg Ulcer (1) · Metabolic Diseases (1) · Musculoskeletal Diseases (1) · Nutritional and Metabolic Diseases (1) · Skin Diseases (1) · Skin Ulcer (1) · Skin and Connective Tissue Diseases (1)
Adrenal Cortex Hormones (1) · Bupivacaine (1) · Methylprednisolone Acetate (1) · Standard of Care (1) · selinexor (1)
Karyopharm Therapeutics Inc (1) · King Hamad University Hospital, Bahrain (1)
Bahrain (1) · New Zealand (1)
Aamina M Khan (1) · Ahsan J Butt (1)